Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18251 - 18275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	FAM223B	286967	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FAM223B mRNA	Xq28	A21749
Copper	Approved Investigational	FAM234A	83986	upregulated	[Disulfiram binds to Copper] which results in increased expression of FAM234A mRNA	16p13.3	A21750
Copper	Approved Investigational	FAM32A	26017	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FAM32A mRNA	19p13.11	A21750
Copper	Approved Investigational	FAM46B	115572	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FAM46B mRNA	1p36.11	A21750
Copper	Approved Investigational	FAM46B	115572	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FAM46B mRNA	1p36.11	A21749
Copper	Approved Investigational	FAM46C	54855	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FAM46C mRNA	1p12	A21750
Copper	Approved Investigational	FAM69B	138311	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM69B mRNA	9q34.3	A21749
Copper	Approved Investigational	FAM76B	143684	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FAM76B mRNA	11q21	A21749
Copper	Approved Investigational	FAM81A	145773	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM81A mRNA	15q22.2	A21749
Copper	Approved Investigational	FAM83D	81610	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM83D mRNA	20q11.23	A21749
Copper	Approved Investigational	FAM84A	151354	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM84A mRNA	2p24.3	A21749
Copper	Approved Investigational	FAM84B	157638	upregulated	[Disulfiram binds to Copper] which results in increased expression of FAM84B mRNA	8q24.21	A21750
Copper	Approved Investigational	FAM86B1	85002	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM86B1 mRNA	8p23.1	A21749
Copper	Approved Investigational	FAM86C1	55199	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAM86C1 mRNA	11q13.4	A21749
Copper	Approved Investigational	FANCA	2175	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FANCA mRNA	16q24.3	A21749
Copper	Approved Investigational	FANCG	2189	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FANCG mRNA	9p13.3	A21749
Copper	Approved Investigational	FAR1	84188	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAR1 mRNA	11p15.3	A21749
Copper	Approved Investigational	FAR2	55711	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAR2 mRNA	12p11.22	A21749
Copper	Approved Investigational	FARP1	10160	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FARP1 mRNA	13q32.2	A21749
Copper	Approved Investigational	FASN	2194	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FASN mRNA	17q25.3	A21749
Copper	Approved Investigational	FAXC	84553	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FAXC mRNA	6q16.2	A21749
Copper	Approved Investigational	FBN1	2200	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FBN1 mRNA	15q21.1	A21749
Copper	Approved Investigational	FBN2	2201	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FBN2 mRNA	5q23.3	A21749
Copper	Approved Investigational	FBXO30	84085	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FBXO30 mRNA	6q24.3	A21749
Copper	Approved Investigational	FBXO5	26271	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FBXO5 mRNA	6q25.2	A21749

Displaying entries 18251 - 18275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability